Eurofins-Cerep SA (PA:ALECR) — Market Cap & Net Worth
Market Cap & Net Worth: Eurofins-Cerep SA (ALECR)
Eurofins-Cerep SA (PA:ALECR) has a market capitalization of $87.26 Million (€74.64 Million) as of August 4, 2026. Listed on the PA stock exchange, this France-based company holds position #19616 globally and #300 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Eurofins-Cerep SA's stock price €16300.00 by its total outstanding shares 5044 (5.04K). See ALECR capex reinvestment rate to understand how much of operating cash flow is reinvested back into capital assets.
Eurofins-Cerep SA Market Cap History: 2025 to 2026
Eurofins-Cerep SA's market capitalization history from 2025 to 2026. Data shows growth from $104.97 Million to $96.12 Million (0.00% CAGR).
Eurofins-Cerep SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Eurofins-Cerep SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.56x
Eurofins-Cerep SA's market cap is 2.56 times its annual revenue
Latest Price to Earnings (P/E) Ratio
21.95x
Eurofins-Cerep SA's market cap is 21.95 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $104.97 Million | $40.98 Million | $4.78 Million | 2.56x | 21.95x |
Competitor Companies of ALECR by Market Capitalization
Companies near Eurofins-Cerep SA in the global market cap rankings as of August 4, 2026.
Key companies related to Eurofins-Cerep SA by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $215.67 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #168 globally with a market cap of $139.50 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #577 globally with a market cap of $46.51 Billion USD ( CN¥317.82 Billion CNY).
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #615 globally with a market cap of $43.83 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $215.67 Billion | $574.03 |
| #168 | Danaher Corporation | NYSE:DHR | $139.50 Billion | $197.50 |
| #577 | WuXi AppTec Co Ltd | SHG:603259 | $46.51 Billion | CN¥128.50 |
| #615 | IDEXX Laboratories Inc | NASDAQ:IDXX | $43.83 Billion | $567.84 |
Eurofins-Cerep SA Historical Marketcap From 2025 to 2026
Between 2025 and today, Eurofins-Cerep SA's market cap moved from $104.97 Million to $ 96.12 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €96.12 Million | -8.43% |
| 2025 | €104.97 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 4th, 2026 the market cap of Eurofins-Cerep SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $87.26 Million USD |
| MoneyControl | $87.26 Million USD |
| MarketWatch | $87.26 Million USD |
| marketcap.company | $87.26 Million USD |
| Reuters | $87.26 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Eurofins-Cerep SA
Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company's research services include compound management, and high-throughput screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was founded in 1989 and… Read more